US Court Rules In Favor Of Viatris For Interchangeable Semglee

Partners Biocon and Viatris To Continue To Market Insulin Glargine Biosimilar

 
• By Akriti Seth
  
Generate a summary of this article
Listen to this article
Beta

Viatris and Biocon continue marketing their recently launched interchangeable biosimilar Semglee (insulin glargine-yfgn) as a US appeals court affirms that the challenged claims of five of Sanofi’s Lantus SoloSTAR device patents are unpatentable.

Court Ruling
Sanofi loses to Viatris as US Court finds challenged claims unpatentable • Source: Alamy

Partners Viatris and Biocon Biologics have announced winning the right to continue providing patients with access to interchangeable biosimilar Semglee (insulin glargine-yfgn) after the US Court of Appeals for the Federal Circuit upheld the US Patent and Trademark Appeal Board’s decisions for unpatentability of five device patents for Sanofi’s Lantus SoloSTAR brand, as well as a district court decision on one of these patents.

In 2020, Mylan – ahead of its merger with Pfizer’s Upjohn to become Viatris – received two favorable decisions on...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products

  • For Generics, A Victory Lap – And A Warning – On Drug Shortages

    Avoiding disaster at the beginning of the pandemic and offering a pro-active supply chain blueprint should position the generics industry well for an onshoring debate in Congress, but a look back at March 2020 is a reminder that even small policy shifts can have a big impact.

  • GB-Free-Company-The Secret to Walking More: It’s Not Counting Steps

    We’ve all been told that walking 10,000 steps a day is the magic number for better health. But what if the real secret to walking more isn’t about counting steps at all? In this article, we explore how focusing on motivation, environment, and mindset can help you build a walking habit that lasts.

  • Biocon And Teva Sign Up To Biosimilars Forum

    Teva and Biocon Biologics have become the latest firms to sign up to the Biosimilars Forum industry association in the US.